TNDM Stock Likely to Gain From Innovation Amid Competition
Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...
TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU
The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...
DexCom: Investors Discounting Long CGM Growth Runway
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Armed robbery in Revesby5d
Research Reveals Normal Glucose Ranges in Non-Diabetics
Participants wore the Dexcom G6 Pro for at least seven days on their arm or abdomen. The sensors measured glucose levels in ...
Researchers present ranges of normal glucose levels among non-diabetic adults wearing continuous glucose monitors
New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are ...